1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > HIV-2 Infection Global Clinical Trials Review, H2, 2014

HIV-2 Infection Global Clinical Trials Review, H2, 2014

  • December 2014
  • -
  • Global Data
  • -
  • 99 pages

HIV-2 Infection Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “HIV-2 Infection Global Clinical Trials Review, H2, 2014" provides data on the HIV-2 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on HIV-2 Infection. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating HIV-2 Infection. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

HIV-2 Infection Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
HIV-2 Infection 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of HIV-2 Infection to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of HIV-2 Infection to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of HIV-2 Infection 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in HIV-2 Infection Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Merck and Co., Inc. 34
Clinical Trial Overview of Merck and Co., Inc. 34
Bristol-Myers Squibb Company 35
Clinical Trial Overview of Bristol-Myers Squibb Company 35
Gilead Sciences, Inc. 36
Clinical Trial Overview of Gilead Sciences, Inc. 36
Pfizer Inc. 37
Clinical Trial Overview of Pfizer Inc. 37
F. Hoffmann-La Roche Ltd. 38
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 38
C. H. Boehringer Sohn AG and Co. KG 39
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 39
Abbott Laboratories 40
Clinical Trial Overview of Abbott Laboratories 40
AbbVie Inc. 41
Clinical Trial Overview of AbbVie Inc. 41
BioCryst Pharmaceuticals, Inc. 42
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 42
Clinical Trial Overview of Top Institutes / Government 43
The National Institute of Allergy and Infectious Diseases 43
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 43
French National Agency for Research on AIDS and Viral Hepatitis 45
Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 45
University of California, San Francisco 46
Clinical Trial Overview of University of California, San Francisco 46
Centers for Disease Control and Prevention 47
Clinical Trial Overview of Centers for Disease Control and Prevention 47
National Center for Complementary and Alternative Medicine 48
Clinical Trial Overview of National Center for Complementary and Alternative Medicine 48
Emory University 49
Clinical Trial Overview of Emory University 49
University of Washington 50
Clinical Trial Overview of University of Washington 50
Hospital Clinic de Barcelona 51
Clinical Trial Overview of Hospital Clinic de Barcelona 51
University of Miami 52
Clinical Trial Overview of University of Miami 52
Stanford University 53
Clinical Trial Overview of Stanford University 53
Five Key Clinical Profiles 54
Appendix 97
Abbreviations 97
Definitions 97
Research Methodology 98
Secondary Research 98
About GlobalData 99
Contact Us 99
Disclaimer 99
Source 99

List of Tables
HIV-2 Infection Therapeutics, Global, Clinical Trials by Region, 2014* 7
HIV-2 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
HIV-2 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
HIV-2 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
HIV-2 Infection Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
HIV-2 Infection Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
HIV-2 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
HIV-2 Infection Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of HIV-2 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
HIV-2 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
HIV-2 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of HIV-2 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
HIV-2 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
HIV-2 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
HIV-2 Infection Therapeutics, Global, Clinical Trials by Phase, 2014* 21
HIV-2 Infection Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
HIV-2 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
HIV-2 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
HIV-2 Infection Therapeutics, Global, Suspended Clinical Trials, 2014* 25
HIV-2 Infection Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
HIV-2 Infection Therapeutics, Global, Terminated Clinical Trials, 2014* 27
HIV-2 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
HIV-2 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
HIV-2 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
HIV-2 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
HIV-2 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 33
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 34
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 35
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 36
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 37
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 38
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2014* 39
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 40
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014* 41
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2014* 42
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 43
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2014* 45
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 46
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2014* 47
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Complementary and Alternative Medicine, 2014* 48
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 49
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 50
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2014* 51
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014* 52
HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 53

List of Figures
HIV-2 Infection Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
HIV-2 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
HIV-2 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
HIV-2 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
HIV-2 Infection Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
HIV-2 Infection Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
HIV-2 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
HIV-2 Infection Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of HIV-2 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
HIV-2 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
HIV-2 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of HIV-2 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
HIV-2 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
HIV-2 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
HIV-2 Infection Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
HIV-2 Infection Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
HIV-2 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
HIV-2 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
HIV-2 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
HIV-2 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
HIV-2 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
HIV-2 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
HIV-2 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 98

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.